1. Home
  2. EVO vs CRTO Comparison

EVO vs CRTO Comparison

Compare EVO & CRTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • CRTO
  • Stock Information
  • Founded
  • EVO 1993
  • CRTO 2005
  • Country
  • EVO Germany
  • CRTO France
  • Employees
  • EVO N/A
  • CRTO N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • CRTO Advertising
  • Sector
  • EVO Health Care
  • CRTO Consumer Discretionary
  • Exchange
  • EVO Nasdaq
  • CRTO Nasdaq
  • Market Cap
  • EVO 1.5B
  • CRTO 1.4B
  • IPO Year
  • EVO 2021
  • CRTO 2013
  • Fundamental
  • Price
  • EVO $4.34
  • CRTO $24.47
  • Analyst Decision
  • EVO Buy
  • CRTO Buy
  • Analyst Count
  • EVO 2
  • CRTO 11
  • Target Price
  • EVO $5.90
  • CRTO $44.70
  • AVG Volume (30 Days)
  • EVO 120.0K
  • CRTO 464.3K
  • Earning Date
  • EVO 08-13-2025
  • CRTO 07-31-2025
  • Dividend Yield
  • EVO N/A
  • CRTO N/A
  • EPS Growth
  • EVO N/A
  • CRTO 107.32
  • EPS
  • EVO N/A
  • CRTO 2.44
  • Revenue
  • EVO $851,944,444.00
  • CRTO $1,934,668,000.00
  • Revenue This Year
  • EVO $10.08
  • CRTO N/A
  • Revenue Next Year
  • EVO $10.99
  • CRTO $1.96
  • P/E Ratio
  • EVO N/A
  • CRTO $9.93
  • Revenue Growth
  • EVO 1.50
  • CRTO N/A
  • 52 Week Low
  • EVO $2.84
  • CRTO $23.24
  • 52 Week High
  • EVO $5.64
  • CRTO $49.93
  • Technical
  • Relative Strength Index (RSI)
  • EVO 57.99
  • CRTO 42.62
  • Support Level
  • EVO $4.15
  • CRTO $23.70
  • Resistance Level
  • EVO $4.33
  • CRTO $24.82
  • Average True Range (ATR)
  • EVO 0.11
  • CRTO 0.82
  • MACD
  • EVO 0.02
  • CRTO 0.19
  • Stochastic Oscillator
  • EVO 85.92
  • CRTO 38.68

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About CRTO Criteo S.A.

Criteo SA is an ad-tech company in the digital advertising market. Its technology, allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. It has two reportable segments: Retail Media and Performance Media. The firm also provides technology allowing retailers to effectively manage their ad inventories and improve yield optimization.

Share on Social Networks: